These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 22161228)
1. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas]. Galldiks N; Langen KJ Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228 [TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences. Heiss WD Eur J Neurol; 2017 Oct; 24(10):1255-e70. PubMed ID: 28799683 [TBL] [Abstract][Full Text] [Related]
3. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging. Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372 [TBL] [Abstract][Full Text] [Related]
6. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706 [TBL] [Abstract][Full Text] [Related]
7. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas. Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386 [TBL] [Abstract][Full Text] [Related]
8. Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas. Seiz M; Dimitrakopoulou-Strauss A; Schubert GA; Weinmann C; Strauss LG; Eisenhut M; Tuettenberg J Hell J Nucl Med; 2008; 11(3):149-52. PubMed ID: 19081856 [TBL] [Abstract][Full Text] [Related]
9. [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids]. Langen KJ; Bartenstein P; Boecker H; Brust P; Coenen HH; Drzezga A; Grünwald F; Krause BJ; Kuwert T; Sabri O; Tatsch K; Weber WA; Schreckenberger M Nuklearmedizin; 2011; 50(4):167-73. PubMed ID: 21789338 [TBL] [Abstract][Full Text] [Related]
10. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas. Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001 [TBL] [Abstract][Full Text] [Related]
11. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET. Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings. Doi Y; Kanagawa M; Maya Y; Tanaka A; Oka S; Nakata N; Toyama M; Matsumoto H; Shirakami Y Nucl Med Biol; 2015 Aug; 42(8):664-72. PubMed ID: 26022202 [TBL] [Abstract][Full Text] [Related]
14. Combined PET/MRI in brain glioma imaging. Almansory KO; Fraioli F Br J Hosp Med (Lond); 2019 Jul; 80(7):380-386. PubMed ID: 31283392 [TBL] [Abstract][Full Text] [Related]
15. Update on amino acid PET of brain tumours. Langen KJ; Galldiks N Curr Opin Neurol; 2018 Aug; 31(4):354-361. PubMed ID: 29952832 [TBL] [Abstract][Full Text] [Related]
17. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[ Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264 [TBL] [Abstract][Full Text] [Related]
18. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193 [TBL] [Abstract][Full Text] [Related]
19. Non-routine Tracers for PET Imaging of High-grade Glioma. Frosina G Anticancer Res; 2016 Jul; 36(7):3253-60. PubMed ID: 27354581 [TBL] [Abstract][Full Text] [Related]
20. The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET. Malkowski B; Harat M; Zyromska A; Wisniewski T; Harat A; Lopatto R; Furtak J PLoS One; 2015; 10(10):e0140917. PubMed ID: 26468649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]